- According to a report by the Confederation of Indian Industry (CII)
and consultancy firm KPMG, the Indian biotechnology sector is likely
to become a US$ 5 billion industry by 2010. The report stated,
"India is ranked among the top 12 biotech destinations in the world
and is the third biggest in Asia-Pacific in terms of the number of
biotech companies."
- The Indian biotech sector's overall turnover in 2008-09 was US$
2.51 billion, as compared to US$ 2.13 billion in 2007-08. Bio-pharma
contributed US$ 1.6 billion; bio-agri nearly US$ 311.28 million,
bio-industrial segment US$ 99.19 million and bio-informatics grew 15
per cent to touch US$ 45.65 million.
- India is already being globally recognised as a manufacturer of
economical, high quality bulk drugs and formulations. With a huge
base of talented, skilled and cost competitive manpower, and a
well-developed scientific infrastructure, India has great potential
to become a leading global player in biotechnology.
- The Bio-pharma sector, comprising vaccines, therapeutics and
diagnostics, generated revenues of around US$ 1.45 billion in
2006-07, with a growth of almost 27 per cent over the previous year.
- The Indian vaccines market is experiencing strong growth The
country posseces the ability to produce large volumes of traditional
vaccines at low costs. Several vaccines are being procured from
India in large volumes by multinational organisations such as GAVI,
UNICEF, PAHO etc. According to UNICEF, India supplies more than 60
per cent of the world's requirement of basic vaccines.
- Hemophiliacs are the target population for players interested in
plasma protein R&D. India needs about 900,000 liters of plasma
proteins per year. India has been meeting this requirement so far by
importing these proteins. None of the other Plasma proteins is being
manufactured in India as yet.
- The bio-services sector has growm by approximately 53 per cent
in 2006-07. The sector contributed revenues of US$ 268 million to
Indian biotechnology, second only to the bio-pharma sector.
Bio-services is also the second fastest growing sector in Indian
biotechnology after Bio-agri.
- Bio-agri is the third largest contributor to Indian biotech
industry during 2006-07 with a turnover of US$ 225 million,
accounting for almost 11 per cent of the biotech pie. However, its
growth rate of almost 55 per cent is the highest among all the
biotech segments.
|
Indian Industry
Scenario
- Biotechnology Industry - Over view
- Indian
Biotechnology Sector
- Industry Sector Focus -
Biotechnology
- Biocon India: A Market & Non-Market
Strategy
- ICICI Knowledge Park
- M. S. Swaminathan Research
Foundation (MSSRF)
- News Letter
- Meerat Institute
of Engineering
- National Dairy Development Board
- India's pharmaceutical market
- The Indian
Pharmaceutical sector
-
The
Ayurvedic Medicine Industry in India
-
Biotechnology in Textile Industry
-
Biotechnology in Tanning Industry
-
Microbial enhanced oil
recovery (MEOR)
-
Biomining
-
Bioplastics
-
Biogums
-
Drug Discovery & Drug Designing
-
patenting in Biotechnology
|
Companies in India
(Sample)
|
Project Data
& Technology
- Entrepreneurship in
Biotechnology Field
- Bioactive Compounds Technology
- Bovin Serum Albumin
- Disposable Blood
Bank System
-
A Process for
Producing Herbicides from a fungus Alternaria alternata
-
Glucose Biosensor Technology
-
Heart Valve
-
Low Cost Plant Tissue Culture
-
Neem Based
Contraceptives
-
Shrimp Feed
-
Targeted Gene Delivery System
-
Thrombinase
-
Oral Pellet Vaccine For Newcastle
Disease
-
Live attenuated Peste des
Petits Ruminants (PPR) Vaccine
-
Monoclonal
antibody based progesterone assay for early Pregnancy diagnosis
in cattle
More Resources
Important Internet Links
|